HanAll Biopharma Major Shareholder Ownership Increases 0.04%

Major shareholder holdings increased by 21,288 shares (0.04%p) to 31.28% (previously 31.24%)
Increase due to executives exercising stock options (Park Seung-guk 13,334 shares, Jung Seung-won 32,334 shares)
Jung Seung-won sold 24,380 shares on market but net increase
Largest shareholder Daewoong Pharmaceutical unchanged at 30.85%

ADVERTISEMENT (250px+)